Ozon Pharm started manufacturing the medicinal products in Togliatti Special Economic Zone. This is the first plant of Russian-origin in SEZ, so as the founder of the resident is a Russian company. In addition, this is currently the only pharmaceutical enterprise at the site.
The new plant opened in the SEZ is one of the most advanced in Russia. It meets the highest European standards in terms of equipment. The plant will produce annually 50 medicines in tablet form for the treatment of various diseases. These are vital and essential drugs, some of which are included in the import substitution plan of the Russian Ministry of Industry and Trade. The enterprise will provide affordable medicinal products to consumers in Russia and CIS.
Ozon Pharm plant is a subsidiary of LLC Ozon, which successfully operates in the Eurasian Economic Union. Today, the founding company is among the leaders of Russian pharmaceutical market and produces more than three hundred million packages of medicines annually.
Currently, the investments made by the resident in project implementation in SEZ amount to almost 1.3 billion rubles, which is significantly exceeds amount planned at the stage of business plan approval.